Stay updated on Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:48:02.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T15:45:57.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error instead of the study information, blocking access to the NCT03832569 details and related content while the site chrome remains visible.
    Difference
    17%
    Check dated 2026-09-21T20:24:24.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The study record shows a revision update to v3.6.6. This indicates a minor maintenance/formatting update to the page rather than a change to study data, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-08-31T18:14:36.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Revision: v3.6.5 appears on the page, replacing v3.6.4. This reflects a minor internal template update with no change to study information or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-10T12:54:05.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page now shows a new revision tag (v3.6.4) replacing the previous v3.6.3. This indicates a minor maintenance update to the page rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-27T06:29:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.